PROBLEM: U.S. AI-chip export controls have reversed direction repeatedly since they began in October 2022: a worldwide license requirement in January 2025, an H20 license requirement in April 2025, H20 licenses with a 15% revenue expectation in August 2025, an H200 announcement with a 25% term in December 2025, and a move to case-by-case review in January 2026. Each reversal changed what was legal to sell and on what terms. There is no disclosure record of the reversals themselves — what changed, when, and what it meant for licenses already granted.
SOLUTION: An export-control reversal disclosure record: every policy reversal logged with the prior rule, the new rule, the effective date, and the treatment of licenses granted under the old rule — so companies and reviewers can see the direction of travel, not just the rule of the day.
EVIDENCE BASIS: DOCUMENTED — the dated events: AI Diffusion rule Jan 15, 2025 (Nvidia 8-K); H20 license requirement Apr 2025; H20 licenses Aug 2025 with 15% expectation (Nvidia 10-Q, no regulation codified); Dec 8, 2025 H200 announcement with 25% term (Reuters); BIS FR Doc. 2026-00789, Jan 15, 2026 (case-by-case review).
| Idea priority | Low |
| Needed By | Not sure -- Just thought it was cool |
By clicking the "Post Comment" or "Submit Idea" button, you are agreeing to the IBM Ideas Portal Terms of Use.
Do not place IBM confidential, company confidential, or personal information into any field.